Modification of the effects of estrogen therapy on HDL cholesterol levels by polymorphisms of the HDL-C receptor, SR-BI: the Rancho Bernardo Study
- 30 June 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 180 (2) , 255-262
- https://doi.org/10.1016/j.atherosclerosis.2004.12.013
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormone replacement therapy (HRT)— risks and benefitsInternational Journal of Epidemiology, 2001
- Cardiovascular Disease and Dyslipidemia in WomenArchives of internal medicine (1960), 2001
- Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic MiceJournal of Biological Chemistry, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levelsNature, 1997
- Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican AmericansCirculation, 1996
- Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein ReceptorScience, 1996
- Genetic and Environmental Influences on Serum Lipid Levels in TwinsNew England Journal of Medicine, 1993
- Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis, 1993